Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhen Zhang has a total of 136 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Network pharmacology and cell experiments suggest natural algal astaxanthin as an anti-atherosclerotic agent via the PPARγ/NF-κB pathway

    by Yunmei Yin, Pei Wang, Zhen Zhang, Hongxiang Zhao, Meicong Xiao, Ran Chen, Kun Li, Shiqi Zhou, Rongqing Zhang


  • Open Access

    An Advanced Lyophilized MSC-Conditioned Medium Formulation Improves Therapeutic Efficacy in Skin Wound Repair

    by Xinjiani Chen, Bailei Li, Wenxue Gu, Mingjuan Li, Zhen Zhang

    The secretome of human umbilical cord mesenchymal stem cells (hUC-MSCs) represents a promising cell-free therapeutic approach for wound healing because of its rich composition of bioactive factors that promote tissue repair. However, the clinical translation of secretome-based therapies is hindered by the instability of its bioactive components during storage. To address this challenge, we developed a lyophilization strategy using cryoprotectants to produce a stable, powdered form of hUC-MSC-conditioned medium (CM). Our results demonstrated that the lyophilized CM (Lyo-CM), particularly when formulated with specific cryoprotectants, maintained excellent bioactivity of CM while showing superior reproducibility and stability. Furthermore, both in vitro and in vivo experiments revealed that Lyo-CM significantly enhanced wound closure during inflammation and proliferation phases, including inflammation resolution, cell proliferation, angiogenesis, and extracellular matrix remodeling. Our study provides a valuable approach to establish a clinically viable, shelf-stable formulation of hUC-MSC secretome to advance the field of cell-free regenerative therapy.

  • Modified chitosan-based hydrogel for sustained release of tetramethylpyrazine and polydatin to promote diabetic wound healing

    by Changle Lu, Bailei Li, Jiali Liu, Xinyu Gao, Zhen Zhang, Yu Zhou, Qilong Cao, Xiaojun Liu, Rong-Qing Zhang

    Diabetic wound healing remains a clinical challenge due to impaired repair, often leading to complications such as infection and tissue necrosis. Here, we present a novel dual-drug-loaded hydrogel formulated using oxidized hyaluronic acid (OHA) and catechol-modified chitosan (CS-pC). This system is engineered to enhance the local bioavailability of polydatin (PD) and delay the release of tetramethylpyrazine (TMP), achieving superior release performance and synergistic effects compared to single-drug formulations; thus, this system enables synergistic modulation of the target inflammatory microenvironment and promotes angiogenesis, thereby facilitating effective diabetic wound healing. The hydrogel exhibited a porous structure (100–200 μm) and moderate swelling (119.67% ± 6.66% at 24 h). Approximately 80% of TMP and PD were sustainably released within 48–52 h, aligning with clinical dressing intervals. In diabetic mice, it accelerated wound closure to 98.01% within 14 days—20.63% higher than controls. Most notably, the hydrogel significantly promoted wound healing, as evidenced by: (1) upregulation of VEGF and α-SMA expression (RT-qPCR: 3.2-fold for VEGF and 3.7-fold for α-SMA vs. control); (2) enhanced cell migration (3.1-fold vs. control) and angiogenesis (1.3-fold vs. control); and (3) increased expression of CD31, TGF-β1 and collagen types I and III (IHC). These results demonstrate the therapeutic potential of the OHA/CS-pC/TMP/PD hydrogel for diabetic wound healing.


  • Interference of algal C-phycocyanin in type 2 diabetes: Mechanisms involving MAPK pathway activation and GLUT4 translocation

    by Hongxiang Zhao, Meicong Xiao, Yunmei Yin, Zhen Zhang, Yunyun Yang, Ran Chen, Kun Li, Pei Wang, Shiqi Zhou, Rongqing Zhang

  • Open Access

    A Phycoerythrin-SOD Fluorescent Probe Enables Detection of Oxidative Stress for Assessing Astaxanthin in NAFLD

    by Kun Li, Zhen Zhang, Ran Chen, Shilin Wu, Ning Yang, Jingyun Chen, Hongxiang Zhao, Pei Wang, Yunmei Yin, Meicong Xiao, et al.

    Objective: To develop a superoxide dismutase (SOD) fluorescent detection probe based on Phycoerythrin (PE) from Porphyridium cruentum for real-time monitoring of SOD activity, a core biomarker of oxidative stress, in a nonalcoholic fatty liver disease (NAFLD) model, and to explore the regulatory effect of astaxanthin. Methods: Phycoerythrin and SOD were covalently coupled using the heterobifunctional cross-linker N-Succinimidyl 3-(2-pyridyldithio) propionate (SPDP), and the probe concentration and incubation time were optimized. A NAFLD model was established in HepG2 cells induced by free fatty acids (FFAs). The fluorescence intensity of the probe was detected by flow cytometry, and the intervention effect of astaxanthin was evaluated by measuring triglyceride (TG)/total cholesterol (TC) contents and SOD activity. Results: The optimal conditions for the Phycoerythrin-SOD probe were determined. Astaxanthin at 20 μM significantly reduced FFA-induced TG (56.8%) and TC (63.6%) contents and restored SOD activity to 60% of that in the control group. Conclusion: The Phycoerythrin-SOD probe serves as an efficient tool for dynamic monitoring of SOD activity in NAFLD. Astaxanthin alleviates liver injury by multi-target regulation of lipid metabolism and antioxidant pathways.

  • Open Access

    Multiscale Design of Dental Restorative Materials: Mechanistic Foundations, Technological Innovations, and Clinical Translation

    by Bailei Li, Ruixue Ai, Xinjiani Chen, Yaning Wang, Chenlei Pan, Suxian Song, Chenjie Yang, Yu Zhou, Zhen Zhang, Xiaojun Liu, et al.

    Dental restorative materials remain constrained by clinical unmet needs in biomechanical durability, bioactivity, and long‐term tissue integration, despite incremental advances in conventional ceramics and polymers. Addressing these gaps requires functional innovation. Multiscale design strategies bridge atomic‐level material engineering with macroscopic clinical performance. This review highlights transformative approaches, including bioinspired architectures (e.g., decellularized extracellular matrix scaffolds) that replicate native oral tissue mechanics while promoting cell‐driven remodeling, and smart interfaces (e.g., pH‐responsive polymers) for dynamic biofilm suppression. Functional enhancements are achieved via 3D printing for anatomically precise restorations, nanotechnology for crack‐resistant ceramics, and surface functionalization (e.g., graphene oxide coatings) to accelerate osseointegration. Emerging paradigms such as 4D‐printed shape‐memory composites and artificial intelligence (AI)‐driven inverse design further exemplify innovation by enabling self‐adapting materials and accelerated discovery of bioactive formulations. Critically, barriers are analyzed to clinical translation, including scalable manufacturing of hierarchical structures, mitigating biodegradation in aggressive oral environments, and balancing cost‐effectiveness with performance. By integrating mechanistic insights with clinical translation, this work provides a blueprint for next‐generation functional dental materials that reconcile laboratory innovation with real‐world clinical demands.


  • A three-step process for purification and stability evaluation of analytical-grade phycocyanin from Spirulina

    by Hongxiang Zhao, Shilin Wu, Zhen Zhang, Ran Chen, Kun Li, Meicong Xiao, Yunmei Yin, Pei Wang, Rongqing Zhang


  • Integrated network pharmacology and cellular assay revealed an anti-type 2 diabetes effect of Astaxanthin from Haematococcus pluvialis

    by Ran Chen, Shilin Wu, Zhen Zhang, Kun Li, Jingyun Chen, Ning Yang, Hongxiang Zhao, Rongqing Zhang

  • Bioengineered Silk Fibroin/Hyaluronic Acid Composite Hydrogel for Minimally Invasive Cartilage Repair

    by Suxian Song, Bailei Li, Xinyu Gao, Zhen Zhang, Yu Zhou, Xiaojun Liu, Rong-Qing Zhang

    With the growing global burden of cartilage degeneration in aging populations and the limitations of conventional surgical interventions, tissue-engineered hydrogels have emerged as a transformative strategy for functional cartilage regeneration. Here, we report an innovative bioinspired composite hydrogel fabricated through carbodiimide-mediated crosslinking of silk fibroin (SF) and hyaluronic acid (HA) using 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (EDC)/N-hydroxysuccinimide (NHS) in MES buffer. The engineered hydrogel exhibited an optimally interconnected porous architecture (pore size: 50-100 μm), tunable compressive modulus ( 86.51 KPa mimicking native cartilage), and swelling performance (570 ± 15%), addressing critical requirements for minimally invasive delivery and mechanical stability. Comprehensive in vitro characterization demonstrated exceptional cytocompatibility, with close to 100% hBMSC viability over 7 days. Most notably, the SF/HA hydrogel significantly promoted chondrogenic differentiation, as evidenced by: (1) 1.8 fold increased in progressive glycosaminoglycan (GAG) deposition (Alcian blue staining), (2) upregulation of SOX9, COL2, and AGG gene expression (RT-qPCR, 1.4, 0.4 and 1.3 fold vs. control), and (3) enhanced type II collagen synthesis (Western blot). These results demonstrate the potential of SF/HA hydrogel for cell-based cartilage repair and osteoarthritis therapy.


  • Open Access

    Intervention of Natural Microalgal Bioactives on Type 2 Diabetes: Integrated Scientometric Mapping and Cellular Efficacy Studies

    by Ran Chen, Hongxiang Zhao, Shilin Wu, Ning Yang, Zhen Zhang, Kun Li, Jingyun Chen, Pei Wang, Xiaojun Liu, Rongqing Zhang

    Type 2 diabetes mellitus (T2DM) is recognized as a multifactorial health disorder associated with various complications. This paper presents a bibliometric analysis of type 2 diabetes mellitus and natural active substances. Currently, the research field in this area is on an upward trajectory, with major research hotspots focusing on pathogenesis, pharmacological activities, the gut microbiota, and lipid metabolism. Algae-derived natural active substances, namely astaxanthin, extracellular polysaccharide from Porphyridium cruentum (EPS-P), and β-carotene, all exhibit high antioxidant properties and safety, along with favorable hypoglycemic effects. Therefore, their therapeutic intervention effects on type 2 diabetes mellitus were evaluated through in vitro experiments. Compared with the model group, astaxanthin, β-carotene, and Porphyridium cruentum polysaccharide (EPS-P) improved various indicators by at least 24.17%, 7.7%, and 6.7%, respectively. All three substances could, to a certain extent, enhance glucose consumption, glycogen content, and pyruvate activity, as well as improve and restore the condition of IR-HepG2 cells. The order of intervention efficacy was astaxanthin, followed by β-carotene, and then Porphyridium cruentum polysaccharide (EPS-P). These findings provide a scientific basis for the biomedical applications of algae-derived natural products.